The role of surgery for children with perianal Crohn's disease

Journal of Pediatric Surgery

Volumn 50, Issue 1, 2015, Pages 140-143

  Seemann, Natashia M ^a   Elkadri, Abdul ^a,b   Walters, Thomas D ^b   Langer, Jacob C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Crohn's disease; Pediatric; Perianal; Surgery

Indexed keywords

AZATHIOPRINE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ABSCESS DRAINAGE; ADOLESCENT; ANUS DISEASE; ARTICLE; CHILD; COLON RESECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; ILEOSTOMY; MAJOR CLINICAL STUDY; MALE; PEDIATRIC SURGERY; PERIANAL CROHN DISEASE; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROCTOCOLECTOMY; RETROSPECTIVE STUDY; SKIN GRAFT; STENOSIS; STOMA STENOSIS; TISSUE INJURY; TREATMENT DURATION; ABSCESS; ANTAGONISTS AND INHIBITORS; COMPLICATION; INFANT; MULTIMODALITY CANCER THERAPY; PERINEUM; PRESCHOOL CHILD; RECTAL FISTULA;

ABSCESS; ADOLESCENT; ANUS DISEASES; CHILD; CHILD, PRESCHOOL; COLECTOMY; COMBINED MODALITY THERAPY; CROHN DISEASE; FEMALE; HUMANS; ILEOSTOMY; INFANT; MALE; PERINEUM; RECTAL FISTULA; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922549079     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2014.10.034     Document Type: Article

References (24)

1. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease inWisconsin: a statewide population-based study. J Pediatr 2003;143:525-31.
2. Markowitz J, Daum F, Aiges H, et al. Perianal disease in children and adolescents with Crohn's disease. Gastroenterologia 1984;86:829-33.
3. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best practice & research. Clin Gastroenterol 2004;18:509-23.
4. Gupta N, Bostrom AG, Kirschner BS, et al. Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol 2008;103: 2092-8.
5. Greenley RN, Hommel KA, Nebel J, et al. Ameta-analytic review of the psychosocial adjustment ofyouthwith inflammatory bowel disease. J Pediatr Psychol 2010;35:857-69.
6. Mackner LM, Crandall WV. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr 2007;19:548-52.
7. Mackner LM, Crandall WV. Long-term psychosocial outcomes reported by children and adolescents with inflammatory bowel disease. Am J Gastroenterol 2005;100: 1386-92.
8. Mackner LM, Crandall WV, Szigethy EM. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:239-44.
9. Mackner LM, Greenley RN, Szigethy E, et al. Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2013;56:449-58.
10. Sandborn WJ, Fazio VW, Feagan BG, et al. AGA technical review on perianal Crohn's disease. Gastroenterologia 2003;125:1508-30.
11. de Zoeten EF, Pasternak BA, Mattei P, et al. Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement. J Pediatr Gastroenterol Nutr 2013;57:401-12.
12. Wong S, Lemberg DA, Day AS. Exclusive enteral nutrition in the management of perianal Crohn's disease in children. J Dig Dis 2010;11:185-8.
13. Hyams J, Crandall W, Kugathasan S, et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterologia 2007;132:863-73.
14. Hyams JS, Griffiths A, Markowitz J, et al. Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children. Gastroenterologia 2012;143:365-74.
15. CrandallW, Hyams J, Kugathasan S, et al. Infliximab therapy in childrenwith concurrent perianal Crohn disease: observations from REACH. J Pediatr Gastroenterol Nutr 2009;49:183-90.
16. Keljo DJ, Markowitz J, Langton C, et al. Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis 2009;15:383-7.
17. de Ridder L, Escher JC, Bouquet J, et al. Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands. J Pediatr Gastroenterol Nutr 2004;39:46-52.
18. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21.
19. Short SS, Dubinsky MC, Rabizadeh S, et al. Distinct phenotypes of children with perianal perforating Crohn's disease. J Pediatr Surg 2013;48:1301-5.
20. Strong SA. Perianal Crohn's disease. Semin Pediatr Surg 2007;16:185-93.
21. Pikarsky AJ, Gervaz P, Wexner SD. Perianal Crohn disease: a new scoring system to evaluate and predict outcome of surgical intervention. Arch Surg 2002;137:774-7 [discussion 778].
22. Satsangi J, Silverberg MS, Vermeire S, et al. TheMontreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53.
23. Hukkinen M, PakarinenMP, Piekkala M, et al. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease. J Crohns Colitis 2014; 8:756-62.
24. Rosen MJ, Moulton DE, Koyama T, et al. Endoscopic ultrasound to guide the combined medical and surgical management of pediatric perianal Crohn's disease. Inflamm Bowel Dis 2010;16:461-8.